Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $28.6 million.

  • Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) rose 114.09% to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year increase of 114.09%. This contributed to the annual value of $16.8 million for FY2024, which is 103.49% up from last year.
  • Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) amounted to $28.6 million in Q3 2025, which was up 0.07% from $28.6 million recorded in Q2 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) peaked at $28.6 million during Q3 2025, and registered a low of $4.4 million during Q1 2021.
  • For the 3-year period, Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) averaged around $15.3 million, with its median value being $13.4 million (2024).
  • Data for Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) shows a peak YoY surged of 246.21% (in 2025) over the last 5 years.
  • Over the past 5 years, Insight Molecular Diagnostics' Shares Outstanding (Weighted Average) (Quarterly) stood at $4.6 million in 2021, then grew by 29.33% to $6.0 million in 2022, then surged by 38.72% to $8.3 million in 2023, then skyrocketed by 103.49% to $16.8 million in 2024, then skyrocketed by 114.09% to $28.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $28.6 million for Q3 2025, versus $28.6 million for Q2 2025 and $28.6 million for Q1 2025.